New International MannKind Patent Application 5/25/2017
May 27, 2017 1:22:51 GMT -5
via mobile
sportsrancho, sla55, and 8 more like this
Post by theforrest on May 27, 2017 1:22:51 GMT -5
Use of Ultrarapid Acting Insulin
Abstract: (EN)
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Application Number: 15421743
Application Date: 01.02.2017
Publication Number: 20170143804
Publication Date: 25.05.2017
Applicants: MannKind Corporation
Inventors: Anders Hasager Boss, Richard Petrucci, Campbell Howard, Alfred Mann
patentscope.wipo.int/search/en/detail.jsf?noMenu=true&docId=US197689019&recNum=4&maxRec=1272&office=&prevFilter=&sortOption=Pub+Date+Desc&navig=existing&queryString=%28MannKind%29
Abstract: (EN)
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Application Number: 15421743
Application Date: 01.02.2017
Publication Number: 20170143804
Publication Date: 25.05.2017
Applicants: MannKind Corporation
Inventors: Anders Hasager Boss, Richard Petrucci, Campbell Howard, Alfred Mann
patentscope.wipo.int/search/en/detail.jsf?noMenu=true&docId=US197689019&recNum=4&maxRec=1272&office=&prevFilter=&sortOption=Pub+Date+Desc&navig=existing&queryString=%28MannKind%29